دورية أكاديمية
Gene Expression Changes and Associated Pathways Involved in the Progression of Prostate Cancer Advanced Stages.
| العنوان: | Gene Expression Changes and Associated Pathways Involved in the Progression of Prostate Cancer Advanced Stages. |
|---|---|
| المؤلفون: | Pudova EA; Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia., Krasnov GS; Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia., Kobelyatskaya AA; Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia., Savvateeva MV; Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia., Fedorova MS; Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia., Pavlov VS; Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia., Nyushko KM; National Medical Research Radiological Center, Ministry of Health of the Russian Federation, Moscow, Russia., Kaprin AD; National Medical Research Radiological Center, Ministry of Health of the Russian Federation, Moscow, Russia., Alekseev BY; National Medical Research Radiological Center, Ministry of Health of the Russian Federation, Moscow, Russia., Trofimov DY; National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov, Ministry of Health of the Russian Federation, Moscow, Russia., Sukhikh GT; National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov, Ministry of Health of the Russian Federation, Moscow, Russia., Snezhkina AV; Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia., Kudryavtseva AV; Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia. |
| المصدر: | Frontiers in genetics [Front Genet] 2021 Jan 21; Vol. 11, pp. 613162. Date of Electronic Publication: 2021 Jan 21 (Print Publication: 2020). |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101560621 Publication Model: eCollection Cited Medium: Print ISSN: 1664-8021 (Print) Linking ISSN: 16648021 NLM ISO Abbreviation: Front Genet Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Original Publication: Lausanne : Frontiers Research Foundation. |
| مستخلص: | Prostate cancer (PC) is one of the most common cancers among men worldwide, and advanced PCs, such as locally advanced PC (LAPC) and castration-resistant PC (CRPC), present the greatest challenges in clinical management. Current indicators have limited capacity to predict the disease course; therefore, better prognostic markers are greatly needed. In this study, we performed a bioinformatic analysis of The Cancer Genome Atlas (TCGA) datasets, including RNA-Seq data from the prostate adenocarcinoma (PRAD; n = 55) and West Coast Dream Team - metastatic CRPC (WCDT-MCRPC; n = 84) projects, to evaluate the transcriptome changes associated with progression-free survival (PFS) for LAPC and CRPC, respectively. We identified the genes whose expression was positively/negatively correlated with PFS. In LAPC, the genes with the most significant negative correlations were ZC2HC1A , SQLE , and KIF11 , and the genes with the most significant positive correlations were SOD3 , LRRC26 , MIR22HG , MEG3 , and MIR29B2CHG . In CRPC, the most significant positive correlations were found for BET1 , CTAGE5 , IFNGR1 , and GIMAP6 , and the most significant negative correlations were found for CLPB , PRPF19 , ZNF610 , MPST , and LINC02001 . In addition, we performed a gene network interaction analysis using STRINGdb, which revealed a significant relationship between genes predominantly involved in the cell cycle and characterized by upregulated expression in early recurrence. Based on the results, we propose several genes that can be used as potential prognostic markers. Competing Interests: The reviewer AT declared a shared affiliation with two of the authors, GS and DT, to the handling editor at time of review. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. (Copyright © 2021 Pudova, Krasnov, Kobelyatskaya, Savvateeva, Fedorova, Pavlov, Nyushko, Kaprin, Alekseev, Trofimov, Sukhikh, Snezhkina and Kudryavtseva.) |
| References: | Cancer Cell. 2005 Jul;8(1):7-12. (PMID: 16023594) PLoS One. 2013 Nov 13;8(11):e79167. (PMID: 24236104) OMICS. 2012 May;16(5):284-7. (PMID: 22455463) Oncogene. 2012 Mar 29;31(13):1673-82. (PMID: 21822313) Cell Rep. 2014 Jul 10;8(1):204-16. (PMID: 24953652) Breast Cancer (Dove Med Press). 2018 May 04;10:69-78. (PMID: 29765247) J Cell Mol Med. 2019 Jan;23(1):29-38. (PMID: 30565858) Nat Rev Drug Discov. 2016 Oct;15(10):699-718. (PMID: 27444228) Eur Rev Med Pharmacol Sci. 2017 Oct;21(17):3850-3856. (PMID: 28975980) Arterioscler Thromb Vasc Biol. 2004 Aug;24(8):1367-73. (PMID: 15166009) Cell Stem Cell. 2014 Jun 5;14(6):752-61. (PMID: 24905165) Nucleic Acids Res. 2017 Jan 4;45(D1):D362-D368. (PMID: 27924014) Mol Med Rep. 2016 Nov;14(5):4119-4123. (PMID: 27667392) Mol Cell Proteomics. 2009 Jan;8(1):32-44. (PMID: 18701445) Genes Dev. 2011 Apr 1;25(7):701-16. (PMID: 21460037) Aging (Albany NY). 2019 Jul 15;11(13):4736-4756. (PMID: 31306099) World J Oncol. 2019 Apr;10(2):63-89. (PMID: 31068988) Lung Cancer. 2008 Dec;62(3):287-94. (PMID: 18462827) Nat Rev Genet. 2016 Jan;17(1):47-62. (PMID: 26666209) Proc Natl Acad Sci U S A. 2013 Jul 23;110(30):12474-9. (PMID: 23836652) Diagn Pathol. 2016 Mar 09;11:25. (PMID: 26956509) Biol Cell. 2012 Dec;104(12):695-705. (PMID: 22967061) Front Genet. 2019 Aug 09;10:730. (PMID: 31447885) Free Radic Biol Med. 2011 Oct 1;51(7):1320-8. (PMID: 21820046) Can Fam Physician. 2013 Dec;59(12):1269-74. (PMID: 24336537) J Cancer. 2019 Sep 7;10(22):5585-5596. (PMID: 31632503) Clin Genitourin Cancer. 2017 Aug;15(4):450-454. (PMID: 27842896) Carcinogenesis. 2017 Aug 1;38(8):806-811. (PMID: 28595267) Handb Exp Pharmacol. 2015;230:233-41. (PMID: 26162838) Bioinformatics. 2010 Jan 1;26(1):139-40. (PMID: 19910308) Cell Res. 2012 May;22(5):806-21. (PMID: 22349460) Math Biosci Eng. 2019 Dec 17;17(2):1776-1786. (PMID: 32233607) Anticancer Res. 2014 Jun;34(6):2821-31. (PMID: 24922645) Curr Opin Pharmacol. 2012 Dec;12(6):751-9. (PMID: 22824430) Nat Rev Cancer. 2019 Dec;19(12):698-715. (PMID: 31666715) Br J Cancer. 2012 Jan 3;106(1):157-65. (PMID: 22075945) Front Oncol. 2020 May 22;10:669. (PMID: 32528873) J Transl Med. 2019 Jun 18;17(1):203. (PMID: 31215439) Gene. 2013 Dec 1;531(2):133-49. (PMID: 23954229) Oncogene. 2012 Oct 25;31(43):4577-87. (PMID: 22266873) |
| فهرسة مساهمة: | Keywords: PFS; PRAD; TCGA; WCDT-MCRPC; gene expression; prostate cancer |
| تواريخ الأحداث: | Date Created: 20210208 Latest Revision: 20210210 |
| رمز التحديث: | 20231215 |
| مُعرف محوري في PubMed: | PMC7859645 |
| DOI: | 10.3389/fgene.2020.613162 |
| PMID: | 33552133 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1664-8021 |
|---|---|
| DOI: | 10.3389/fgene.2020.613162 |